日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response

细胞可渗透的铁螯合剂M606通过E2F3介导的反应抑制MYCN驱动的神经母细胞瘤。

Pandher, Ruby; Xue, Chengyuan; Gamble, Laura D; Milazzo, Giorgio; Di Giacomo, Simone; Murray, Jayne; Cheung, Leanna; Ferrucci, Francesca; Palombo, Marta; Purgato, Stefania; Burkhart, Catherine A; Fedtsova, Natalia; Gleiberman, Anatoli S; Purmal, Andrei A; Korotchkina, Lioubov; Nikiforov, Mikhail A; Makarov, Sergei S; Telfer, Thomas J; Codd, Rachel; Marshall, Glenn M; Scott, David A; Osterman, Andrei L; Gudkov, Andrei V; Perini, Giovanni; Haber, Michelle; Norris, Murray D

A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomas

一项针对四肢黑色素瘤和肉瘤的动脉内注射 CBL0137 的 1 期研究

Skitzki, Joseph J; Kim, Minhyung; Fisher, Daniel T; Kane, John M 3rd; Yu, Han; Catalfamo, Kayla; Tomaszewski, Garin; Petroziello, Michael; Purmal, Andrei; Gurova, Katerina V; Gudkov, Andrei V

Opportunities to Address Specialty Care Deserts and the Digital Divide through the Veterans Health Administration's Telehealth Hub-and-Spoke Cardiology Clinic: Retrospective Cohort Study

通过退伍军人健康管理局的远程医疗中心辐射式心脏病诊所解决专科医疗服务匮乏和数字鸿沟问题的机会:回顾性队列研究

Tisdale, Rebecca Lauren; Purmal, Colin; Kalwani, Neil; Sandhu, Alexander; Heidenreich, Paul; Zulman, Donna; Hussain, Tanvir

FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair

FACT抑制剂CBL0137以优化的给药方案给药,可通过抑制DNA损伤修复来增强放射疗法治疗胶质母细胞瘤的效果。

Barone, Tara A; Robinson, Denisha L; Qiu, Jingxin; Gurova, Katerina V; Purmal, Andrei A; Gudkov, Andrei V; Plunkett, Robert J

Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery

CBL0137 的化学优化,用于发现人类非洲锥虫病的先导药物

Baljinder Singh, Amrita Sharma, Naresh Gunaganti, Mitch Rivers, Pradip K Gadekar, Brady Greene, Michael Chichioco, Carlos E Sanz-Rodriguez, Courtney Fu, Catherine LeBlanc, Erin Burchfield, Nyle Sharif, Benjamin Hoffman, Gaurav Kumar, Andrei Purmal, Kojo Mensa-Wilmot, Michael P Pollastri

Editorial: Cleft Lip and Palate Anomalies/Syndromes

社论:唇腭裂畸形/综合征

Alam, Mohammad Khursheed; Moniruzzaman, Mohammed; Purmal, Kathiravan

Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development

非洲人类锥虫病药物研发的先导药物 CBL0137 的生理目标和作用方式

Carlos E Sanz-Rodríguez, Benjamin Hoffman, Paul J Guyett, Andrei Purmal, Baljinder Singh, Michael P Pollastri, Kojo Mensa-Wilmot

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

用于治疗应用的去免疫化和药理学优化的 Toll 样受体 5 激动剂

Vadim Mett, Oleg V Kurnasov, Ivan A Bespalov, Ivan Molodtsov, Craig M Brackett, Lyudmila G Burdelya, Andrei A Purmal, Anatoli S Gleiberman, Ilia A Toshkov, Catherine A Burkhart, Yakov N Kogan, Ekaterina L Andrianova, Andrei V Gudkov, Andrei L Osterman

The emerging role of clinical informatics fellows in service learning during the COVID-19 pandemic

临床信息学研究员在新冠疫情期间服务学习中日益凸显的作用

Subash, Meera; Sakumoto, Matthew; Bass, Jeremy; Hong, Peter; Muniyappa, Anoop; Pierce, Logan; Purmal, Colin; Ramaswamy, Priya; Sono, Reiri; Uptegraft, Colby; Feinstein, David; Khanna, Raman

Curaxin CBL0137 has the potential to reverse HIV-1 latency

Curaxin CBL0137 有可能逆转 HIV-1 潜伏期

Maxime J Jean, Dawei Zhou, Guillaume Fiches, Weili Kong, Huachao Huang, Andrei Purmal, Katerina Gurova, Netty G Santoso, Jian Zhu